André B. P. Kuilenburg

Amsterdam Neuroscience (NL)

Research Areas

Discover Papers by André B. P. Kuilenburg

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

Publications

1747

Citations

15604

i10-index

222

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Histone deacetylases (HDACs): characterization of ...	2003	3087
Dihydropyrimidine dehydrogenase and the efficacy a...	2004	486
Thalassemia Syndromes	2009	475
DPYD genotype-guided dose individualisation of flu...	2018	413
Reduced replication of 3TC-resistant HIV-1 variant...	1996	410
Clinical relevance of DPYD variants c.1679T>G, ...	2015	371
Clinical implications of dihydropyrimidine dehydro...	2000	360
Genotype and phenotype in patients with dihydropyr...	1999	282
Lethal outcome of a patient with a complete dihydr...	2001	255
Prevalence of a common point mutation in the dihyd...	2001	232

Publications

1.
Histone deacetylases (HDACs): characterization of the classical HDAC family
Year: 2003Citations: 3087DOI: 10.1042/bj20021321
2.
Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil
Year: 2004Citations: 486DOI: 10.1016/j.ejca.2003.12.004
3.
Thalassemia Syndromes
Year: 2009Citations: 475DOI: 10.1007/978-3-540-29676-8_1731
4.
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis
Year: 2018Citations: 413DOI: 10.1016/s1470-2045(18)30686-7
5.
Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
Year: 1996Citations: 410DOI: 10.1002/j.1460-2075.1996.tb00777.x
6.
Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data
Year: 2015Citations: 371DOI: 10.1016/s1470-2045(15)00286-7
7.
Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene.
Year: 2000Citations: 360
8.
Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency
Year: 1999Citations: 282DOI: 10.1007/pl00008711
9.
Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G>A mutation causing DPD deficiency.
Year: 2001Citations: 255
10.
Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.
Year: 2001Citations: 232

About André B. P. Kuilenburg

André B. P. Kuilenburg is a researcher with 1747 publications and 15604 citations. They are affiliated with Amsterdam Neuroscience. Their research focuses on . With an h-index of 58, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from André B. P. Kuilenburg and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year